NORTHERN TRUST CORP - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 42 filers reported holding OCUPHIRE PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$103,415
-23.5%
30,870
-1.0%
0.00%
Q2 2023$135,265
+12.5%
31,167
-2.8%
0.00%
Q1 2023$120,263
+52.9%
32,070
+43.9%
0.00%
Q4 2022$78,652
+74.8%
22,2810.0%0.00%
Q3 2022$45,000
+4.7%
22,2810.0%0.00%
Q2 2022$43,000
-35.8%
22,281
+7.4%
0.00%
Q1 2022$67,000
-13.0%
20,746
+0.7%
0.00%
Q4 2021$77,000
+24.2%
20,596
+69.8%
0.00%
Q3 2021$62,00012,1310.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 340,526$1,276,9762.16%
Knoll Capital Management, LLC 100,000$375,0000.58%
RICE HALL JAMES & ASSOCIATES, LLC 809,117$3,034,1890.17%
Diametric Capital, LP 55,648$208,6800.10%
MAI Capital Management 494,690$1,855,0880.03%
TRUST CO OF TOLEDO NA /OH/ 26,000$97,5000.02%
Bedel Financial Consulting, Inc. 15,000$56,2500.01%
Legato Capital Management LLC 16,456$61,7100.01%
OCCUDO QUANTITATIVE STRATEGIES LP 19,623$73,5860.01%
Cornerstone Capital, Inc. 16,357$61,3390.01%
View complete list of OCUPHIRE PHARMA INC shareholders